Takayuki Shiraki

Dokkyo Medical University

Papers

1

Total Citations

9

H-Index

1

About

Dr. Takayuki Shiraki is a leading figure in colorectal surgical oncology, whose work has significantly advanced the field of minimally invasive rectal cancer treatment. His primary research focuses on the comparative outcomes of robotic versus conventional laparoscopic surgery, particularly regarding the oncological precision of total mesorectal excision. Dr. Shiraki’s major contribution is a landmark systematic review and meta-analysis, which demonstrated that robotic surgery is associated with a significantly decreased risk of circumferential resection margin (CRM) positivity compared to traditional laparoscopic approaches. This finding is critical, as CRM involvement is a key predictor of local recurrence and survival. His 2024 meta-analysis, already garnering 9 citations, provides high-level evidence supporting the adoption of robotic techniques to improve surgical quality. By rigorously evaluating surgical margins and operative outcomes, Dr. Shiraki’s work directly informs clinical decision-making, helping surgeons select the optimal approach for rectal cancer patients. His research continues to shape best practices in colorectal surgery, emphasizing the importance of technological innovation in achieving superior oncologic results.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Robotic surgery is associated with a decreased risk of circumferential resection margin positivity compared with conventional laparoscopic surgery in patients with rectal cancer undergoing mesorectal excision: A systematic review and meta-analysis
9 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Dokkyo Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago